Drug giant faced a reckoning as China took aim at bribery
"The Glaxo case, which resulted in record penalties of nearly $500 million and a string of guilty pleas by executives, upended the power dynamic in China, unveiling an increasingly assertive government determined to tighten its grip over multinationals."
China in 2 minutes a day
More from SupChina
Friday, December 02
Dec 02, 2016